T39. NEURAL MECHANISMS OF METABOTROPIC GLUTAMATE RECEPTOR 3 MEDIATED ENHANCEMENT OF SYNAPTIC PLASTICITY AND COGNITION

由 Stansley, Branden, Joffe, Max, Yohn, Samantha, Lindsley, Craig, Niswender, Colleen, Jeffrey Conn, P
發表在 Schizophr Bull (2018)

3293 Region Specific Dysregulation of Dopaminergic Signaling in Mice Displaying Excessive Over-Grooming

由 Foster, Daniel, Yohn, Samantha, Mahmood, Muhammad, Lavery, Madigan, O’Brien, Daniel, Peng, Weimin, Jeffrey Conn, P.
發表在 J Clin Transl Sci (2019)

T227. THE METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 REGULATES STRIATAL DOPAMINE RELEASE VIA AN ENDOCANNABINOID-DEPENDENT MECHANISM: IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA

由 Yohn, Samantha, Covey, Daniel, Foster, Daniel, Moehle, Mark, Galbraith, Jordan, Cheer, Joseph, Lindsley, Craig, Jeffrey Conn, P
發表在 Schizophr Bull (2018)

Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology

由 Sengmany, Kathy, Hellyer, Shane D., Albold, Sabine, Wang, Taide, Jeffrey Conn, P., May, Lauren T., Christopoulos, Arthur, Leach, Katie, Gregory, Karen J.
發表在 Neuropharmacology (2019)

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

由 Shen, Weixing, Plotkin, Joshua L., Francardo, Veronica, Ko, Wai Kin D., Xie, Zhong, Li, Qin, Fieblinger, Tim, Wess, Jürgen, Neubig, Richard R., Lindsley, Craig W., Jeffrey Conn, P., Greengard, Paul, Bezard, Erwan, Angela Cenci, M., James Surmeier, D.
發表在 Neuron (2016)